TEVA PHARMACEUTICAL INDUSTRIES LTD
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 1, 2026 | TD Cowen | initiate | — → Buy | — | 54% |
| Sep 23, 2026 | Oppenheimer | initiate | — → Outperform | — | 52% |
No cross-platform signals in the last 90 days